GlaxoSmithKline Consumer Healthcare Ltd. - Research Center
500676 GSKCONS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Dec' 19 | Sep' 19 | Jun' 19 | Mar' 19 | Dec' 18 | |
|---|---|---|---|---|---|
| Sales | 1,158.86 | 1,345.09 | 1,194.32 | 1,286.06 | 1,116.82 |
| Operating profit | 272.08 | 395.81 | 280.40 | 318.48 | 238.53 |
| Interest | 1.49 | 1.78 | 1.70 | 0.20 | 0.21 |
| Gross profit | 386.63 | 472.16 | 405.28 | 441.17 | 362.57 |
| EPS (Rs) | 65.77 | 82.10 | 58.98 | 67.95 | 52.56 |
Quarterly
results in details
| Dec' 19 | Sep' 19 | Jun' 19 | Mar' 19 | Dec' 18 | |
|---|---|---|---|---|---|
| Other income | 116.04 | 78.13 | 126.58 | 122.89 | 124.25 |
| Stock adjustment | -22.17 | -4.34 | 22.59 | -0.10 | -68.36 |
| Raw material | 349.54 | 364.40 | 309.86 | 360.68 | 360.44 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 151.71 | 159.30 | 184.25 | 164.83 | 156.72 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | 142.92 | 139.66 | 142.69 | 190.86 | 134.90 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 264.78 | 290.26 | 254.53 | 251.31 | 294.59 |
| Provisions made | - | - | - | - | - |
| Depreciation | 19.17 | 20.33 | 19.62 | 14.92 | 15.81 |
| Taxation | 90.83 | 106.52 | 137.58 | 140.44 | 125.70 |
| Net profit / loss | 276.63 | 345.31 | 248.08 | 285.81 | 221.06 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 42.06 | 42.06 | 42.06 | 42.06 | 42.06 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 23.48 | 29.43 | 23.48 | 24.76 | 21.36 |
| GPM (%) | 30.33 | 33.18 | 30.68 | 31.31 | 29.21 |
| NPM (%) | 21.70 | 24.26 | 18.78 | 20.29 | 17.81 |
Mutual Fund Selector
Find the fund that is right for you
© 2020 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis